| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.52 | 0.08 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.35 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.34 | 4e-10 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.33 | 0.01 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.31 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.24 | 4e-06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-10 |